Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia

Early identification of patients at risk of developing preeclampsia (PE) would allow providers to tailor their prenatal management and adopt preventive strategies, such as low-dose aspirin. Nevertheless, no mid-trimester biomarkers have as yet been proven useful for prediction of PE. This study inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Mi, Kang, Yujin, Lee, Eun Mi, Jung, Young Mi, Hong, Subeen, Park, Soo Jin, Park, Chan-Wook, Norwitz, Errol R., Lee, Do Yup, Park, Joong Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527521/
https://www.ncbi.nlm.nih.gov/pubmed/32999354
http://dx.doi.org/10.1038/s41598-020-72852-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527521/
https://www.ncbi.nlm.nih.gov/pubmed/32999354
http://dx.doi.org/10.1038/s41598-020-72852-4

Ejemplares similares